Disclaimer

PLEASE READ THIS NOTICE CAREFULLY. IT REGULATES YOUR USE OF THE ALIZYME PLC WEB SITE AND ALL MATERIAL WITHIN IT. YOUR ACCESS TO THIS WEB SITE IS DEEMED AN ACCEPTANCE OF THE CONTENTS OF THIS NOTICE.

Content
The material contained in this web site is a guide for general information purposes only. This site does not provide or offer medical advice and its contents should not be relied upon as such. Nor should anything contained in this web site be deemed to be a recommendation for any particular treatment or drug.

Although Alizyme plc has made every effort to ensure that the information contained in this web site is correct, you should be aware that the information may be incomplete, inaccurate or may have become out of date. To the extent permitted by law, neither Alizyme plc nor Alizyme Therapeutics Limited, nor their officers, employees or agents shall be liable for any loss, damage or expense arising out of or in connection with any access to or use of the content of this web site, including, without limitation, any loss of profit, indirect, incidental or consequential loss.

Alizyme plc reserves the right to add to, withdraw, change or correct any material contained in this web site as and when it considers it appropriate and without notice.

This web site contains forward-looking statements with respect to the financial condition and results of Alizyme plc’s business. These statements involve risk and uncertainty because they relate to the future and there are a number of factors which could cause actual results or developments to differ materially from such forward-looking statements.

Nothing in this web site is intended as a recommendation to buy, sell or hold any securities of Alizyme plc. Nothing in this web site constitutes an offer to invest in, subscribe for or purchase any such securities, nor does it constitute an advertisement or promotion of such securities. No person should rely on any of the material in this web site in making any decision to purchase or invest in securities of Alizyme plc. Advice should always be sought from a suitably qualified independent financial adviser.

The disclaimers and exclusions contained in this legal message shall be governed by and construed in accordance with English law. If any provision of these disclaimers and exclusions shall be unlawful, void, or for any reason unenforceable, then such provision shall be deemed severable and shall not affect the validity and enforceability of the remaining provisions.

Should you decide to access this web site from a territory outside the United Kingdom, you will be responsible for compliance with applicable local laws.

Independent Auditors' Report
Neither an audit nor a review provides assurance on the maintenance and integrity of the website, including controls used to achieve this, and in particular on whether any changes may have occurred to the financial information since first published. These matters are the responsibility of the directors but no control procedures can provide absolute assurance in this area.

Legislation in the United Kingdom governing the preparation and dissemination of financial information differs from legislation in other jurisdictions.

Links
Alizyme plc assumes no responsibility for the content of any other web sites to which this web site has links or access, or from which this web site is linked or accessed. This web site may not be linked by any other web site without first obtaining the written permission of Alizyme plc.

Copyright
You are responsible for obeying all applicable copyright laws. The copyright in the material contained in this web site is owned by either Alizyme plc (or Alizyme Therapeutics Limited) or its content provider. With the exception of copying that is necessary and incidental to the viewing of this web site, and copying for personal, non-commercial purposes, no part of this web site may be copied, used, changed, re-published or broadcast without first obtaining the written permission of Alizyme plc.

Registered Trademarks
COLAL^® and COLAL-PRED^® are registered trademarks of Alizyme Therapeutics Limited.




©Alizyme plc 1996 - 2006. All rights reserved, and all moral rights are asserted and reserved.